戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 from the development of in utero obstructive uropathy.
2 ronic renal failure secondary to obstructive uropathy.
3 ied at 4-6 months of age from an obstructive uropathy.
4 g the pathobiology of congenital obstructive uropathy.
5 es ischemic hypoxic insults, and obstructive uropathy.
6 anding of the pathophysiology of obstructive uropathy.
7 nal insufficiency as a result of obstructive uropathy.
8  use of medications for treating obstructive uropathy.
9 ty associated significantly with obstructive uropathy.
10 ary tract infection, trauma, and obstructive uropathy.
11 ble insight into a wide range of obstructive uropathies.
12 ue insights into a wide range of obstructive uropathies and has been demonstrated to be useful in the
13 ease characterized by congenital obstructive uropathy and abnormal facial expression.
14                                  Obstructive uropathy and dysplasia were the cause of CRI in 92% of t
15     Urinary tract malformations, obstructive uropathy, and hypoplasia/dysplasia are extremely importa
16 al cell fate and nephron loss in obstructive uropathy are not fully understood.
17 emic bowel (75%); the lowest was obstructive uropathy-associated urinary tract infection (26%).
18                          Chronic obstructive uropathy (COU) created by unilateral ureteric ligation i
19 t animals exhibit seizures and/or obstuctive uropathy, each of unknown cause.
20 rvention has been done for fetal obstructive uropathy for over a decade, yet little is known about lo
21 n the fetus as it is affected by obstructive uropathy has had no significant advances in the past yea
22 urrent study, a model of chronic obstructive uropathy in the mouse is established and the role of lym
23                                  Obstructive uropathy is the most common complication, although other
24                       In a mouse obstructive uropathy model of chronic kidney disease, interstitial f
25  postischemic renal fibrosis and obstructive uropathy, treatment with N-terminal Slit2 before or afte
26 iteria), exclusion criteria were obstructive uropathy, urothelial carcinoma, and metastatic cancer.
27 es with the most severe forms of obstructive uropathy, usually associated with a fatal neonatal cours
28 standing the mechanisms of fetal obstructive uropathy will be essential for the specific management o

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。